Literature DB >> 13023980

[Cytostasis due to triethylene melamine (TEM) in lymphogranulomatosis and chronic leukemia].

C NEUMANN.   

Abstract

Entities:  

Keywords:  HODGKIN'S DISEASE/therapy; LEUKEMIA/therapy; TRIETHYLENE MELAMINE/therapeutic use

Mesh：

Substances：

Year:  1952        PMID： 13023980     DOI： 10.1007/bf01471994

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  6 in total

1.  The influence of nitrogen mustard on mycosis fungoides; observations relating its effect to the reticulo-endothelial system.

Authors:  H H HENSTELL; J N TOBER; B A NEWMAN
Journal:  Blood       Date:  1947-11       Impact factor: 22.113

2.  Remissions caused by tri-ethylene melamine in certain neoplastic diseases. A preliminary report.

Authors:  L T WRIGHT; J C WRIGHT; A PRIGOT; S WEINTRAUB
Journal:  J Natl Med Assoc       Date:  1950-11       Impact factor: 1.798

3.  Triethylene melamine in the treatment of neoplastic disease; a compound with nitrogen-mustardlike activity suitable for oral and intravenous use.

Authors:  D A KARNOFSKY; J H BURCHENAL; G C ARMISTEAD; C M SOUTHAM; J L BERNSTEIN; L F CRAVER; C P RHOADS
Journal:  AMA Arch Intern Med       Date:  1951-04

4.  [Effect of cortisone, triethylene melamine and oligo-elements in a case of acute leukemia in a child].

Authors:  N BOVET-DU BOIS; H DUBOIS-FERRIERE; W BLANC; A VOGT
Journal:  Praxis       Date:  1951-04-19

5.  New cytotoxic agents with tumour-inhibitory activity.

Authors:  F L ROSE; J A HENDRY; A L WALPOLE
Journal:  Nature       Date:  1950-06-24       Impact factor: 49.962

6.  [Triethylene melamine therapy of malignant granulomatosis and certain other malignant diseases].

Authors:  P B HANSEN; J BICHEL
Journal:  Nord Med       Date:  1952-01-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.